Literature DB >> 10601091

Mice with Y chromosome deletion and reduced Rbm genes on a heterozygous Dazl1 null background mimic a human azoospermic factor phenotype.

T Vogel1, R M Speed, P Teague, H J Cooke.   

Abstract

A subset of azoospermia or oligozoospermia patients have microdeletions in defined regions of their Y chromosome, namely the AZFa, b, and c regions. Candidate genes in humans that may cause the azoospermia factor (AZF) phenotype have been assigned to these regions and can include the DAZ and RBM genes. Part of the variability in the AZFc phenotype might be due to interaction between the effects of deleting the DAZ and RBM genes. We mimicked human deletions of RBM and DAZ in the mouse by crossing male mice with a deleted Y chromosome with a reduced number of Rbm genes (Y(d1)) to heterozygote Dazl1 null female mice to study the interaction of the Dazl1 and Rbm or other genes located in the Y(d1) deletion interval. Dazl-/+ Y(d1) animals showed a significant reduction in the sperm count (P < 0.001), an increase of abnormal sperm heads and prominent mid-piece defects of the tails compared to either mutation alone (P < 0.001). Hence, Dazl1 and the genes removed on the Y(d1) chromosome are active in different pathways contributing to different stages of spermatogenesis. Reduction of Dazl1 and Rbm genes as well as/or deletion of the Y chromosome in mice gives rise to a phenotype similar to the heterogeneous AZFc phenotype observed in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10601091     DOI: 10.1093/humrep/14.12.3023

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  2 in total

1.  Molecular screening for Yq microdeletion in men with idiopathic oligozoospermia and azoospermia.

Authors:  Rima Dada; N P Gupta; K Kucheria
Journal:  J Biosci       Date:  2003-03       Impact factor: 1.826

2.  Human Y-chromosome variation and male dysfunction.

Authors:  Cláudia Márcia Benedetto de Carvalho; Fabrício Rodrigues Santos
Journal:  J Mol Genet Med       Date:  2005-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.